{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:31:18Z","timestamp":1760315478875,"version":"build-2065373602"},"reference-count":88,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Nursing Clinics of North America"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ccell.2010.03.001","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T04:48:47Z","timestamp":1280983727000},"page":"351-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatorenal Syndrome: A Comprehensive Overview for the Critical Care Nurse"],"prefix":"10.1016","volume":"22","author":[{"given":"James N.","family":"Fleming","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Abou","family":"Abbass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2010.03.001_bib1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(56)90149-0","article-title":"Electrolyte and circulatory changes in terminal liver failure","volume":"271","author":"Hecker","year":"1956","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ccell.2010.03.001_bib2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM196906192802501","article-title":"Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease","volume":"280","author":"Koppel","year":"1969","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.ccell.2010.03.001_bib3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJM197311292892201","article-title":"Recovery from \u201chepatorenal syndrome\u201d after orthotopic liver transplantation","volume":"289","author":"Iwatsuki","year":"1973","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccell.2010.03.001_bib4","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.2006.107789","article-title":"Diagnosis, prevention, and treatment of hepatorenal syndrome in cirrhosis","volume":"84","author":"Salerno","year":"2008","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ccell.2010.03.001_bib6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","article-title":"Hepatorenal syndrome: pathophysiology and management","volume":"1","author":"Wadei","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ccell.2010.03.001_bib7","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1172\/JCI105679","article-title":"Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion","volume":"46","author":"Tristani","year":"1967","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.ccell.2010.03.001_bib8","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0002-9343(70)80074-2","article-title":"Plasma renin levels in hepatic cirrhosis. Relationship to functional renal failure","volume":"49","author":"Schroeder","year":"1970","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ccell.2010.03.001_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-1007296","article-title":"Hepatorenal disorders: role of the sympathetic nervous system","volume":"14","author":"Henriksen","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ccell.2010.03.001_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0016-5085(79)90268-3","article-title":"Effects of indomethacin and prostaglandin A1 in renal function and plasma renin activity in alcoholic liver disease","volume":"77","author":"Boyer","year":"1979","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ccell.2010.03.001_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0168-8278(97)80318-2","article-title":"Splanchnic and extrasplanchnic arterial hemodynamics in patients with cirrhosis","volume":"27","author":"Iwao","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ccell.2010.03.001_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0168-8278(87)80569-X","article-title":"Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome","volume":"5","author":"Solis-Herruzo","year":"1987","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ccell.2010.03.001_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jhep.2004.09.008","article-title":"Cardiac alterations in cirrhosis: reversibility after liver transplantation","volume":"42","author":"Torregrosa","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.ccell.2010.03.001_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccell.2010.03.001_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/153537020623100108","article-title":"Accumulation of symmetric dimethylarginine in hepatorenal syndrome","volume":"231","author":"Lluch","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.ccell.2010.03.001_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2010.03.001_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2010.03.001_bib21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ccell.2010.03.001_bib22","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors, and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib23","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gines","year":"1988","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ccell.2010.03.001_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/jhep.2001.27830","article-title":"Renal failure after upper GI bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis","volume":"34","author":"Cardenas","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0016-5085(82)90129-9","article-title":"Aminoglycoside nephrotoxicity in cirrhosis: value of urinary \u03b22-microglobulin to discriminate functional renal failure from acute tubular damage","volume":"82","author":"Cabrera","year":"1982","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ccell.2010.03.001_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the Consensus Conference of the International Ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ccell.2010.03.001_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1665-2681(19)32189-1","article-title":"Treatment of cirrhotic tense ascites with dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial","volume":"1","author":"Garcia-Compean","year":"2002","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ccell.2010.03.001_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1742-1241.1998.tb08933.x","article-title":"Low-dose dopamine infusion in cirrhosis with refractory ascites","volume":"52","author":"Lin","year":"1998","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.ccell.2010.03.001_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0090-6980(78)90130-2","article-title":"Combined use of dopamine and prostaglandin A1 in patients with acute renal failure and hepatorenal syndrome","volume":"15","author":"Vincenti","year":"1978","journal-title":"Prostaglandins"},{"issue":"1","key":"10.1016\/j.ccell.2010.03.001_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00003246-199501000-00031","article-title":"Reversal of hepatorenal syndrome with the combination of norepinephrine and dopamine","volume":"23","author":"Durkin","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccell.2010.03.001_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.510300430","article-title":"Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine","volume":"30","author":"Gulberg","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","article-title":"Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion","volume":"27","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.30.1.90","article-title":"Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis","volume":"30","author":"Lenz","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.ccell.2010.03.001_bib34","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1345\/aph.1H373","article-title":"Terlipressin: vasopressin analogue and novel drug for septic shock","volume":"40","author":"Presurato","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ccell.2010.03.001_bib35","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2010.03.001_bib36","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","article-title":"Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with terlipressin: a retrospective analysis","volume":"17","author":"Colle","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.ccell.2010.03.001_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ccell.2010.03.001_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized, placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ccell.2010.03.001_bib39","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib40","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs. albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2010.03.001_bib41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case control study","volume":"40","author":"Restuccia","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.ccell.2010.03.001_bib42","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib43","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/hep.510230541","article-title":"Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats","volume":"23","author":"Seiber","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib44","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ccell.2010.03.001_bib45","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfh930","article-title":"Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study","volume":"20","author":"Kiser","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ccell.2010.03.001_bib46","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1345\/aph.1D513","article-title":"Effects of continuous vasopressin infusion in patients with septic shock","volume":"38","author":"Obritsch","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ccell.2010.03.001_bib47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type 1 HRS: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patient with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ccell.2010.03.001_bib49","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenalin versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ccell.2010.03.001_bib50","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0016-5085(03)00377-9","article-title":"Transjugular intrahepatic portosystemic shunt: current status","volume":"124","author":"Boyer","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2010.03.001_bib51","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/hep.1840220536","article-title":"The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Disease Advisory Board","volume":"25","author":"Shiffman","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-116-4-304","article-title":"Using transjugular intrahepatic portosystemic shunt to control variceal bleeding before liver transplantation","volume":"116","author":"Ring","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccell.2010.03.001_bib53","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1053\/gast.1996.v110.pm8608893","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) vs. esclerotherapy in the elective treatment of variceal haemorrhage","volume":"110","author":"Cabrera","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2010.03.001_bib54","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/01.meg.0000236872.85903.3f","article-title":"Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome","volume":"18","author":"Senzolo","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ccell.2010.03.001_bib55","first-page":"709","article-title":"Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function","volume":"21","author":"Somberg","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib56","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199505043321803","article-title":"The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites","volume":"332","author":"Ochs","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccell.2010.03.001_bib57","doi-asserted-by":"crossref","first-page":"816","DOI":"10.7326\/0003-4819-122-11-199506010-00002","article-title":"Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites","volume":"122","author":"Wong","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccell.2010.03.001_bib58","doi-asserted-by":"crossref","first-page":"1024A","DOI":"10.1016\/0016-5085(95)28397-8","article-title":"Treatment of hepatorenal syndrome with the transjugular intrahepatic portosystemic shunt (TIPS)","volume":"108","author":"Alam","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2010.03.001_bib59","first-page":"1169","article-title":"Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt","volume":"90","author":"Spahr","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ccell.2010.03.001_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00004836-199504000-00016","article-title":"Hepatorenal syndrome: resolution after transjugular intrahepatic portosystemic shunt","volume":"20","author":"Sturgis","year":"1995","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.ccell.2010.03.001_bib61","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib62","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(97)24010-9","article-title":"Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome [letter]","volume":"349","author":"Brensing","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2010.03.001_bib63","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.20559","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension","volume":"41","author":"Boyer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib64","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","article-title":"Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study","volume":"126","author":"Bureau","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2010.03.001_bib65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cld.2006.08.004","article-title":"Transjugular intrahepatic portosystemic shunt: role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax","volume":"10","author":"LaBerge","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ccell.2010.03.001_bib66","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.mcna.2008.03.007","article-title":"The hepatorenal syndrome","volume":"92","author":"Munoz","year":"2008","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ccell.2010.03.001_bib67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1081\/JDI-200035988","article-title":"The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis","volume":"26","author":"Capling","year":"2004","journal-title":"Ren Fail"},{"key":"10.1016\/j.ccell.2010.03.001_bib68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00003246-199303000-00007","article-title":"Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure","volume":"21","author":"Davenport","year":"1993","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccell.2010.03.001_bib69","first-page":"717","article-title":"The management of renal failure in patients at risk of cerebral edema\/hypoxia","volume":"3","author":"Davenport","year":"1995","journal-title":"New Horiz"},{"key":"10.1016\/j.ccell.2010.03.001_bib70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000102127","article-title":"Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock","volume":"156","author":"Hirasawa","year":"2007","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.ccell.2010.03.001_bib71","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.ccell.2010.03.001_bib72","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1440-1746.2004.03471.x","article-title":"Which patients benefit from hemodialysis therapy in hepatorenal syndrome?","volume":"19","author":"Witzke","year":"2004","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.ccell.2010.03.001_bib73","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","article-title":"Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy","volume":"68","author":"Wong","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ccell.2010.03.001_bib74","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/lt.500060326","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.ccell.2010.03.001_bib75","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1526-0968.2001.00388.x","article-title":"Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system","volume":"5","author":"Mitzner","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.ccell.2010.03.001_bib76","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2008.174615","article-title":"Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in cirrhotic patients with ascites who have failed vasoconstrictor therapy","volume":"59","author":"Wong","year":"2009","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ccell.2010.03.001_bib77","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1600-6143.2009.02567.x","article-title":"Liver and intestine transplantation in the United States 1998\u20132007","volume":"9","author":"Berg","year":"2009","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ccell.2010.03.001_bib78","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep.1840170302","article-title":"Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis","volume":"17","author":"Navasa","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2010.03.001_bib79","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Weisner","year":"2003","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ccell.2010.03.001_bib80","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ccell.2010.03.001_bib81","first-page":"159","article-title":"Pretransplant renal dysfunction predicts poorer outcome in liver transplantation","volume":"49","author":"Lafayette","year":"1997","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ccell.2010.03.001_bib82","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","article-title":"Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation","volume":"35","author":"Nair","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ccell.2010.03.001_bib83","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","article-title":"Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome\u2014experience in 300 patients","volume":"51","author":"Gonwa","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.ccell.2010.03.001_bib84","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type 1 hepatorenal syndrome post liver transplantation","volume":"21","author":"Marik","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.ccell.2010.03.001_bib85","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/lt.20445","article-title":"Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation","volume":"11","author":"Campbell","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ccell.2010.03.001_bib86","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archsurg.141.8.735","article-title":"Long-term analysis of combined liver and kidney transplantation at a single center","volume":"141","author":"Ruiz","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.ccell.2010.03.001_bib87","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1432-2277.2009.00887.x","article-title":"Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD-era","volume":"22","author":"Schmitt","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.ccell.2010.03.001_bib88","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of consensus conference on\u00a0simultaneous liver kidney transplantation (SLK)","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant"}],"container-title":["Critical Care Nursing Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899588510000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899588510000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:26:06Z","timestamp":1760268366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899588510000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0899588510000080"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2010.03.001","relation":{},"ISSN":["0899-5885"],"issn-type":[{"type":"print","value":"0899-5885"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatorenal Syndrome: A Comprehensive Overview for the Critical Care Nurse","name":"articletitle","label":"Article Title"},{"value":"Critical Care Nursing Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2010.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}